EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
about
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population.Quality evaluation of methyl binding domain based kits for enrichment DNA-methylation sequencing.Anti-EGFR function of EFEMP1 in glioma cells and patient prognosis.Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.DNA methylation of GSTP1 in human prostate tissues: pyrosequencing analysisMitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes.EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer.A genome-wide association study identifies four novel susceptibility loci underlying inguinal hernia.EFEMP1 rs3791679 polymorphism was associated with susceptibility to glioma.Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer.Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.Biomarkers in prostate cancer epidemiology.Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics.The genomic landscape of prostate cancerSeminal plasma as a diagnostic fluid for male reproductive system disorders.Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate CancerEpigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomasPromoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer.Clinical significance of epigenetic silencing and re-expression of O6-methylguanine-DNA methyltransferase using epigenetic agents in laryngeal carcinoma.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling.Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
P2860
Q24628879-60252944-F1A5-493B-BCB6-5DD9BC7DB2DCQ33914032-EC199C04-9121-48D7-B844-29ABA7D9DB69Q34648668-C7F11676-17FC-4768-BA36-2434CF879AA7Q34781171-A50D227D-29A3-4DE9-98F2-27B7764FFD19Q34807396-10B81E80-AB12-4F4B-9AB8-22A90332F1D9Q35120213-5C35D3D5-4EE6-4010-9719-6E18DFF301EAQ35478122-ED37455E-2EDA-43D0-B922-DCE8A717720CQ35852010-6AAF3606-74C5-4F64-8057-9C3BD7AA0415Q35882554-EA045E10-8DA5-425E-86E7-E38DB5CFE335Q35987298-2774527B-E581-41B0-890F-A9FE7DAB4A83Q36081391-D10D6752-D47F-4387-B13C-9C710544A21AQ36108833-DE9F3378-45B6-4B79-8819-F30D8664D638Q36400527-62DB62B0-2327-4CC1-A27F-0A10772BF818Q36437954-BD3136C8-B162-4909-B855-C664C4185FC6Q36464923-17A0F408-6D23-427D-8206-E664641981E9Q36705589-1FE92C18-5E2D-4B25-9EA8-70CD8EBFF620Q36794310-08C1EF8F-4402-46B2-967B-E28B30403BFDQ37064102-23F6DAB2-0659-46E7-9F3D-53EDC2333D5FQ37148139-20C5B544-B288-438A-9693-2A932A87C50EQ37298184-D560D646-5C7A-4361-99AB-68E16EA7999AQ38109474-0391EAE8-FFFA-411E-8200-338695BE42B5Q38202841-DBEC3BB9-C89A-4677-877B-2A042F06D657Q38721452-A319E67B-B756-4563-BD6A-B1B05DF27C26Q38957460-A52EF9FB-D26F-443F-8645-9551958154C4Q39042581-36B20041-8907-4AD9-BA49-97A73C7E93CDQ41709616-03EFEF44-BA75-4CBC-ACAE-25E6A4F1C7C0Q41751900-88C38CE0-3061-47F0-8525-AAF7C4928C3CQ42676794-0A0695A0-51AA-4B4C-8F62-1FE877CCFBC6Q45716446-DCC4BA5A-36EB-4CF0-9CD7-75165F6C13CEQ51600504-8B0FF87B-E939-422E-91F2-6BD3E7AA636F
P2860
EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@en
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@nl
type
label
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@en
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@nl
prefLabel
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@en
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@nl
P2093
P1476
EFEMP1 as a novel DNA methylat ...... tion and expression profiling.
@en
P2093
Eun-Jung Kim
Hyung-Yoon Yoon
Isaac Yi Kim
Seon-Kyu Kim
Wun-Jae Kim
Yong-June Kim
Young-Won Kim
P304
P356
10.1158/1078-0432.CCR-10-2817
P407
P577
2011-05-13T00:00:00Z